American Health & Drug Benefit recently published an article co-authored by our CEO, Lisa Bloudek. The article discusses the cost implications of adopting intravenous cetirizine in an emergency department setting to treat acute urticaria from a hospital perspective.

The article, “Are Drugs Priced in Accordance with Value? A Comparison of Value-Based and Net Prices Using Institute for Clinical and Economic Review Reports” co-authored by Lisa Bloudek, Curta Partner and CEO, Sean D. Sullivan, Curta Partner and President, and Victor Nguyen, along with University of Washington Affiliate faculty Jens Grueger, received the 2022 Value in Health Paper of the Year Award.

Our CEO, Lisa Bloudek, was named by Puget Sound Business Journal as part of their 2022 class of 40 Under 40. This year’s class includes professionals from the field of healthcare, tech, hospitality, and non-profit, among many others.

Curta is presenting a poster at ASCO 2022 titled Approach to Estimating the Population-Level Benefit from Avelumab Maintenance Therapy in Metastatic Urothelial Carcinoma.

Curta’s Chief Medical Officer, Scott Ramsey, was quoted in an article by Dhruv Khullar for The New Yorker. The article discusses the advancement of therapies for sickle cell disease over time and the challenges related to accessing gene therapy.

March’s issue of the Journal of Managed Care & Specialty Pharmacy features an article by one of our partners, Josh Carlson, and contracted collaborator, Ryan Hansen.

The Journal of Managed Care & Specialty Pharmacy recently published a systematic review by one of our partners Josh Carlson.

The Journal of Managed Care & Specialty Pharmacy recently published findings by the Institute for Clinical and Economic Review, featuring two of Curta’s very own, Lizzy Brouwer and Josh Carlson.

Curta proudly welcomes expert health economists Sean Sullivan, Scott Ramsey, David Veenstra, and Josh Carlson as partners.

From everyone at Curta, happy holidays and best wishes in the new year!

Our work to compare and contrast published cost-effectiveness models for chronic rhinosinusitis with nasal polyps will be presented Tuesday, November 30 at the ISPOR EU virtual meeting.

Curta has multiple posters on display at AMCP Nexus 2021. Stop in and check out some of our latest research.

In this study, the authors explored the unmet need of locally advanced/metastatic urothelial cancer by assessing outcomes from randomized controlled trials of 1L therapies regimens against the standard of care.

Congratulations to Lisa and the other authors for getting their research published in the Journal of Managed Care & Specialty Pharmacy.

Congratulations to our very own Elizabeth Brouwer for publishing part of her dissertation research in the Journal of Managed Care & Specialty Pharmacy.

We are happy to introduce the newest additions to our team!

We are happy to introduce the newest additions to our team!

Researchers from Curta and the University of Washington partnered on a manuscript comparing how the Institute of Clinical and Economic Review (ICER) value-based prices compare to list prices of recently approved drugs.